Back to Search
JAMES MACKEY, MD
MD
Medical Oncology Physician
NPI: 1356388870IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L2999(TX)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Class of 2000
Research & Publications (20)
Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role.
PMID 19557823·Psychooncology·2010
8-other
The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer.
PMID 19672422·Curr Oncol·2009
8-other
Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction.
PMID 19482248·Lancet Oncol·2009
6-review
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.
PMID 19204205·J Clin Oncol·2009
8-other
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
PMID 19318496·Clin Cancer Res·2009
8-other
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
PMID 19351764·Clin Cancer Res·2009
8-other
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
PMID 19436700·PLoS Pathog·2009
7-preclinical
Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.
PMID 19435692·Bull Cancer·2009
4-observational
Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training.
PMID 19622583·Clin Cancer Res·2009
8-other
Prospective cohort study of lifetime physical activity and breast cancer survival.
PMID 19123472·Int J Cancer·2009
8-other
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.
PMID 18992248·Gastroenterology·2009
3-trial
Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy.
PMID 18389368·Breast Cancer Res Treat·2009
2-rct
[Design and implementation of a national serum bank for the surveillance of exotic animal diseases in the Republic of Cuba].
PMID 19284045·Rev Sci Tech·2008
6-review
Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: a case study.
PMID 18930676·Mol Genet Metab·2008
5-case
Effects of aerobic exercise training in anemic cancer patients receiving darbepoetin alfa: a randomized controlled trial.
PMID 18779540·Oncologist·2008
2-rct
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.
PMID 18766181·Br J Cancer·2008
6-review
Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study.
PMID 18644703·Clin Oncol (R Coll Radiol)·2008
4-observational
Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
PMID 18604194·Mod Pathol·2008
8-other
Infection prevention and control competencies for hospital-based health care personnel.
PMID 19084164·Am J Infect Control·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 431 E STATE HIGHWAY 114 STE 470
SOUTHLAKE, TX 76092 - Phone
- (817) 416-0202
Quick Facts
- NPI
- 1356388870
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile